IP Library › Granted Patent US 7,556,808
Granted Patent B2
US 7,556,808 · App. 11/305,401 · Granted Jul 7, 2009

Dual inhibitors of HIV-1 gp-120 interactions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,556,808
App. No.
11/305,401
Granted
Jul 7, 2009
Kind
B2
Abstract

Compounds, which inhibit the binding of gp120 to CD4 as well as 17b and methods for their use in inhibiting the HIV fusion process, are provided.

Claims (3)

1. An isolated peptide consisting of SEQ ID NO: 5.

2. A composition comprising the peptide of claim 1 .

3. A method of inhibiting the binding of HIV to cell surface receptor CD4, said method comprising contacting cells infected with HIV with the composition of claim 2 .

Assignments (3)
MERGER Recorded Jan 14, 2015
From: PHILADELPHIA HEALTH & EDUCATION CORPORATION
To: DREXEL UNIVERSITY
Reel/Frame 034764/0236 →
CONFIRMATORY LICENSE Recorded Jan 6, 2010
From: 1/4/2010
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023741/0036 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2006
From: HOSAHUDYA, GOPI; CHAIKEN, IRWIN
To: PHILADELPHIA, HEALTH AND EDUCATION CORPORATION
Reel/Frame 017603/0354 →